Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2004. Start Trial.
Date Value
October 22, 2026 124.89
October 21, 2026 128.53
October 20, 2026 133.75
October 19, 2026 133.75
October 16, 2026 133.75
October 15, 2026 133.98
October 14, 2026 133.98
October 13, 2026 133.98
October 12, 2026 128.53
October 09, 2026 128.53
October 08, 2026 128.53
October 07, 2026 128.53
October 06, 2026 128.53
October 05, 2026 124.89
October 02, 2026 124.89
October 01, 2026 129.44
September 30, 2026 129.44
September 29, 2026 129.21
September 28, 2026 129.21
September 25, 2026 122.62
September 24, 2026 122.62
September 23, 2026 122.62
September 22, 2026 129.44
September 21, 2026 110.36
September 18, 2026 110.13
Date Value
September 17, 2026 108.77
September 16, 2026 108.77
September 15, 2026 109.79
September 14, 2026 110.27
September 11, 2026 117.63
September 10, 2026 117.63
September 09, 2026 124.89
September 08, 2026 117.17
September 04, 2026 110.07
September 03, 2026 113.54
September 02, 2026 111.02
September 01, 2026 113.54
August 31, 2026 110.75
August 28, 2026 113.54
August 27, 2026 113.54
August 26, 2026 113.54
August 25, 2026 113.54
August 24, 2026 129.44
August 21, 2026 129.44
August 20, 2026 131.71
August 19, 2026 124.89
August 18, 2026 136.02
August 17, 2026 139.54
August 14, 2026 137.82
August 13, 2026 149.87

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 2.793
Corcept Therapeutics, Inc. 13.14
Veru, Inc. 1.346
Johnson & Johnson 7.792
Eli Lilly & Co. 35.41

Price to Book Value Related Metrics

PEG Ratio -0.5961
Price 0.055
Earnings Yield -5.27%
Market Cap 3.285M
PEGY Ratio -0.5961